Browse the evidence

Okra mucilage has medicinal applications as a plasma replacement or blood volume expander and is used in Asian medicine as a protective food additive against gastric diseases.

Okra mucilage has been used medicinally as a plasma expander and to treat gastric diseases. While not a standard home remedy, its properties are recognized in some medicinal contexts.

Non-glycaemic carbohydrates (NSP, Resistant Starch) provide health benefits through fermentation in the large intestine, producing SCFAs and reducing fecal ammonia, but their benefits are not universal and depend on specific chemical properties.

Include a variety of non-glycaemic carbohydrates like whole grains, legumes, and vegetables. These provide fiber (NSP) and resistant starch, which feed gut bacteria and produce beneficial short-chain fatty acids. However, do not rely on isolated fiber supplements to replicate the benefits of whole foods, as the food matrix is crucial.

Infant formula milk contains significantly higher levels of Advanced Glycation End Products (AGEs), specifically CML, compared to breast milk, potentially predisposing infants to inflammation and metabolic issues.

If using infant formula, be aware that processing creates AGEs. Follow preparation instructions carefully to avoid excessive heating. If breastfeeding is possible, it provides lower AGE exposure. For formula-fed infants, this is a known physiological factor contributing to early inflammatory load.

Gut microbiota-derived lipopolysaccharides (LPS) and peptidoglycan (PGN) promote NAFLD progression by activating hepatic Toll-like receptors (TLR4, TLR2, NOD1/2), triggering inflammatory cytokine release and steatosis.

Your liver health is heavily influenced by what lives in your gut. An unhealthy diet can disrupt gut bacteria, allowing harmful bacterial parts (like LPS) to leak into your bloodstream and inflame your liver. Prioritizing a diet that supports a healthy gut microbiome (e.g., high fiber) may help reduce this inflammatory load on the liver.

Gut microbiota-derived metabolites, specifically Short-Chain Fatty Acids (SCFAs) like butyrate, acetate, and propionate, ameliorate NAFLD by inhibiting histone deacetylases (HDACs) and activating G-protein coupled receptors (GPR41, GPR43).

Eating soluble dietary fibers feeds gut bacteria to produce Short-Chain Fatty Acids (SCFAs) like butyrate. These metabolites help reduce liver inflammation and fat accumulation by regulating gene expression and immune responses. Focus on fiber-rich foods rather than isolated SCFA supplements.

Gut microbiota-derived Trimethylamine-N-oxide (TMAO) and secondary bile acids modulate NAFLD progression through regulation of bile acid metabolism, insulin resistance, and hepatic inflammation.

The conversion of dietary nutrients (choline, carnitine) by gut bacteria into TMA, and subsequently TMAO in the liver, influences bile acid metabolism and insulin resistance. Managing dietary intake of these precursors and supporting healthy bile acid signaling (via secondary bile acids) may help manage NAFLD.

Gut microbiota dysbiosis, characterized by elevated pathobionts (e.g., Proteobacteria, Enterobacteriaceae) and depleted beneficial bacteria (e.g., Faecalibacterium, Bifidobacterium), is associated with gestational diabetes mellitus (GDM) and postpartum glucose intolerance, potentially serving as a predictive biomarker for type 2 diabetes.

If you have or had GDM, your gut bacteria may look different from those without GDM, resembling the profile of type 2 diabetes. While this doesn't mean you are doomed, it suggests that maintaining a healthy gut through diet and lifestyle might be a key strategy for preventing type 2 diabetes after pregnancy. Consult your doctor about monitoring your metabolic health.

Gut microbiota dysbiosis in GDM involves elevated lipopolysaccharide (LPS) production and translocation, leading to low-grade inflammation and insulin resistance.

High levels of certain gut bacteria (pathobionts) can lead to inflammation and insulin resistance. While this is a key mechanism in GDM, it is not yet clear if fixing the microbiota alone will cure GDM. Focus on overall metabolic health.

The effects of Baduanjin Qigong on leg power, cardiopulmonary endurance, and pulmonary function remain unclear due to a small number of studies.

Do not rely on Baduanjin Qigong as your primary method for improving leg power, cardiovascular endurance, or lung capacity. While it may offer minor benefits, there is not enough evidence to confirm it effectively targets these specific physiological systems. For these goals, consider more targeted aerobic or resistance training.

Thyroid dysfunction (both hypo- and hyperthyroidism) is bidirectionally associated with metabolic syndrome components, where thyroid hormones regulate metabolic rate, adiposity, and glucose/lipid metabolism, while adiposity and insulin resistance reciprocally affect thyroid function via leptin and inflammatory cytokines.

If you have metabolic syndrome or obesity, your thyroid health is likely affected, and vice versa. High TSH is associated with higher risk of metabolic syndrome components like high blood pressure, triglycerides, and insulin resistance. Conversely, losing weight and improving insulin sensitivity can improve thyroid function markers. Do not assume treating thyroid levels alone will resolve metabolic issues; address adiposity and insulin resistance concurrently.

Lack of formal obesity management training during medical school and residency significantly reduces the likelihood of primary care clinicians discussing diet and exercise with obese patients.

If you are a healthcare provider, your willingness to discuss diet and exercise with obese patients is strongly linked to the quality of your formal medical training. If you feel unprepared, seek out specific education on obesity management rather than relying solely on your personal health habits.

Clinicians who monitor their own diets with high vigilance are significantly more likely to calculate the BMI of obese patients than those who are less vigilant about their diet.

Your personal habits regarding diet and exercise may influence how thoroughly you screen your patients for obesity. If you are not vigilant about your own diet, you may be less likely to calculate BMI, which is a critical first step in obesity management.

System-level barriers such as lack of insurance payment for obesity care are not prevalent barriers to obesity management in the VHA setting.

If you are in a system like the VHA where obesity services are covered, do not use lack of insurance payment as an excuse for not managing obesity. Focus on improving your own training and awareness of available services.

Defective nitric oxide (NO) production and mitochondrial biogenesis are central mechanisms driving visceral adiposity, insulin resistance, and cardiovascular risk in the metabolic syndrome.

If you struggle with obesity and insulin resistance, standard calorie counting may fail because your body's energy sensors (mitochondria) are defective, signaling an 'energy emergency' that drives hunger and reduces energy expenditure. Addressing the root cause may require interventions that support mitochondrial health and nitric oxide production, rather than just focusing on willpower or simple caloric restriction, which might further suppress already defective lipid oxidation.

Dysregulation of specific microRNAs (miRNAs) in adipose tissue, pancreas, liver, and muscle contributes to the pathogenesis of obesity and related metabolic diseases by altering gene expression involved in energy balance, insulin signaling, and inflammation.

Obesity involves complex biological regulation beyond just calories in vs. calories out. Specific microRNAs in your fat, liver, and muscle cells can become dysregulated, contributing to insulin resistance and inflammation. While lifestyle changes remain foundational, understanding this biological layer explains why obesity can be stubborn and why future treatments may target these specific molecular pathways.

Circulating microRNAs (miRNAs) found in plasma and other body fluids can serve as biomarkers for obesity and metabolic diseases, and may act as endocrine signaling molecules mediating inter-organ communication.

Blood tests may soon be able to detect specific microRNAs that indicate metabolic stress or obesity-related risks before clinical symptoms appear. This could lead to earlier interventions. Additionally, fat tissue may release these molecules to communicate with other organs, influencing metabolism system-wide.

Specific microRNAs (e.g., miR-143, miR-145, miR-27a, miR-130a) regulate adipogenesis (fat cell formation) and insulin sensitivity, with some promoting and others inhibiting fat cell differentiation and glucose homeostasis.

The formation of new fat cells is tightly controlled by specific microRNAs. Some miRNAs encourage fat storage (like miR-143), while others prevent it (like miR-27a). This biological regulation explains why fat distribution and insulin sensitivity vary significantly between individuals.

Obesity is associated with gut dysbiosis characterized by decreased microbial diversity and an increased Firmicutes/Bacteroidetes ratio, which contributes to obesity through disrupted energy homeostasis, lipid synthesis, and chronic inflammation.

Your gut bacteria play a significant role in how your body handles energy and stores fat. While diet and exercise are crucial, the types of bacteria in your gut can influence your risk of obesity through mechanisms like energy extraction and inflammation. Maintaining gut health through a diverse diet may support metabolic health, but it is not a standalone cure for obesity.

Altered gut microbiota in obesity increases digestible energy uptake from food through enhanced expression of nutrient transporters and fermentation enzymes, leading to increased caloric absorption.

Your gut bacteria can extract more calories from the same amount of food if they are altered. This is one reason why two people might eat the same diet but have different weights. Focusing on gut health through fiber and diverse foods might help optimize energy extraction.

Gut microbiota alterations in obesity contribute to chronic low-grade inflammation through increased lipopolysaccharide (LPS) translocation, which triggers immune responses and insulin resistance.

High levels of bacterial toxins (LPS) can leak into your bloodstream if your gut barrier is compromised, causing inflammation and insulin resistance. A diet rich in fiber and fermented foods may support gut barrier integrity.

Treatment with trans-10,cis-12 conjugated linoleic acid (CLA) reduces triglyceride accumulation in human preadipocytes by decreasing insulin-stimulated glucose uptake, glucose oxidation, and oleic acid uptake/oxidation, while downregulating PPARγ expression and target genes.

This research indicates that a specific form of CLA (trans-10,cis-12) can reduce fat storage in human fat cells by slowing down how they process sugars and fats. However, this was done in a lab dish, not in people. Do not expect this to cause weight loss on its own. It suggests that not all CLA supplements are created equal, and some may even work against fat loss goals by reducing metabolic activity in fat cells.

Caloric restriction extends lifespan and delays age-related decline by activating SIRT1, which deacetylates and activates eNOS to improve vascular function and reduce oxidative stress.

To leverage this mechanism, consider implementing caloric restriction (e.g., reducing intake by 10-20% without malnutrition) to potentially activate SIRT1. This may improve vascular function and reduce oxidative stress, contributing to healthier aging. Consult a healthcare provider before making significant dietary changes.

Orexin system deficiency or dysfunction causes obesity in animal models by reducing spontaneous physical activity (SPA) and energy expenditure, independent of caloric intake.

Focus on increasing spontaneous physical activity (fidgeting, standing, non-exercise movement) as a metabolic lever. If you struggle with weight despite dieting, consider that your body's arousal/energy regulation systems (potentially involving orexin) might be suppressing your natural movement. Incorporating more non-exercise movement may help regulate energy expenditure.

Physical exercise increases cerebrospinal fluid and plasma levels of Orexin-A, which may contribute to exercise-induced hippocampal neurogenesis and cognitive benefits.

Engage in regular physical exercise. Beyond physical fitness, this increases Orexin-A levels, which may support brain health, neurogenesis, and cognitive performance by crossing the blood-brain barrier.